Cardiac glycosides are natural sterols and constitute a group of secondary metabolites isolated from plants and animals. These cardiotonic agents are well recognised and accepted in the treatment of various cardiac diseases as they can increase the rate of cardiac contractions by acting on the cellular sodium potassium ATPase pump. However, there has also been recent interest in exploring the antitumour and antiviral potential of these compounds.1
This is a companion discussion topic for the original article at https://patient.info/doctor/cardiovascular-disease/digoxin-and-the-cardiac-glycosides